The efficacy, safety, and feasibility of inhaled amikacin for the treatment of difficult-to-treat non-tuberculous mycobacterial lung diseases.
Yagi K, Ishii M, Namkoong H, Asami T, Iketani O, Asakura T, Suzuki S, Sugiura H, Yamada Y, Nishimura T, Fujiwara H, Funatsu Y, Uwamino Y, Kamo T, Tasaka S, Betsuyaku T, Hasegawa N.
Yagi K, et al. Among authors: tasaka s.
BMC Infect Dis. 2017 Aug 9;17(1):558. doi: 10.1186/s12879-017-2665-5.
BMC Infect Dis. 2017.
PMID: 28793869
Free PMC article.